Medication may help address particular symptoms or co-occurring conditions during recovery from methamphetamine use. There is currently no FDA-approved medication specifically for methamphetamine use disorder.
This guide distinguishes symptom care, off-label research and ongoing treatment. A prescriber considers the individual’s health, symptoms, other substances and goals before recommending medication.
Research into reducing methamphetamine use is different from an established medication protocol for withdrawal. Off-label use means a medication approved for another condition is being considered outside that approved indication.
Behavioral treatment and monitoring remain central. Severe depression, psychosis or inability to stay safe needs urgent assessment; call 911 for immediate danger or a medical emergency.
1. Bupropion (Wellbutrin)
Bupropion is an antidepressant studied in stimulant-use treatment, including in combination with injectable naltrexone. It is not FDA-approved for methamphetamine use disorder or a universal withdrawal treatment.
A prescriber reviews potential benefits, interactions and risks, including seizure risk, before considering it.
2. Naltrexone
Naltrexone has approved uses for alcohol and opioid use disorders. Research on naltrexone with bupropion does not make either medicine an approved meth-withdrawal treatment.
Current opioid use and opioid-treatment medication are important to disclose because naltrexone can precipitate opioid withdrawal.
3. Modafinil (Provigil)
Modafinil is approved for certain sleep-related conditions. It should not be presented as a standard or proven medication for methamphetamine withdrawal.
If discussed, ask the prescriber about the evidence, risks and alternatives for your particular symptoms.
4. Mirtazapine (Remeron)
Mirtazapine is an antidepressant that has been studied for reducing methamphetamine use in some populations. The findings do not establish it as an approved or universally effective withdrawal medication.
Depression, sleep, other conditions and medication risks require individual review.
5. Topiramate (Topamax)
Topiramate has approved uses for other conditions and has been studied in stimulant-use treatment. It is not an FDA-approved methamphetamine treatment.
Discuss the evidence, side effects and monitoring with the prescriber rather than selecting a medicine from a list.
Nirvana Recovery's Integrated Treatment Approach
Nirvana treats adult substance-use and co-occurring mental-health needs using CBT, DBT skills, Seeking Safety and motivational interviewing. Treatment plans are reviewed weekly with client input.
Medical and psychiatric appointments take place by telehealth, with follow-up weekly and as needed. Medication decisions are individualized. Admissions coordinates outside withdrawal care or stabilization when needed before Nirvana treatment.
Clients practice coping skills between sessions and review progress with their clinician, connecting therapy with changes in daily life.
Conclusion
Call Admissions at (480) 764-2335 to discuss methamphetamine treatment, mental-health support, program fit and preparation for care. Bring your medication list and questions for the clinical assessment.
Prescription access does not mean a medicine is appropriate for methamphetamine treatment. A prescriber must evaluate the indication, evidence, risks and monitoring needs.
No medication is currently FDA-approved specifically for methamphetamine use disorder. The medicines discussed have other approved indications; any proposed off-label use requires individual clinical review.
Medication decisions are prescriber-led and part of an individualized plan. Nirvana provides therapy and telehealth medical and psychiatric follow-up, with outside withdrawal care or stabilization coordinated when needed.
Ask what symptom or condition is being treated, the evidence for the proposed use, side effects, interactions and follow-up plan. Do not start, stop or change prescriptions based on this article.
Medications and Support for Meth Withdrawal in Arizona
Published On March 28, 2024
Medication may help address particular symptoms or co-occurring conditions during recovery from methamphetamine use. There is currently no FDA-approved medication specifically for methamphetamine use disorder.
This guide distinguishes symptom care, off-label research and ongoing treatment. A prescriber considers the individual’s health, symptoms, other substances and goals before recommending medication.
Table of Contents
Medications Studied in Methamphetamine Treatment
Research into reducing methamphetamine use is different from an established medication protocol for withdrawal. Off-label use means a medication approved for another condition is being considered outside that approved indication.
Behavioral treatment and monitoring remain central. Severe depression, psychosis or inability to stay safe needs urgent assessment; call 911 for immediate danger or a medical emergency.
1. Bupropion (Wellbutrin)
Bupropion is an antidepressant studied in stimulant-use treatment, including in combination with injectable naltrexone. It is not FDA-approved for methamphetamine use disorder or a universal withdrawal treatment.
A prescriber reviews potential benefits, interactions and risks, including seizure risk, before considering it.
2. Naltrexone
Naltrexone has approved uses for alcohol and opioid use disorders. Research on naltrexone with bupropion does not make either medicine an approved meth-withdrawal treatment.
Current opioid use and opioid-treatment medication are important to disclose because naltrexone can precipitate opioid withdrawal.
3. Modafinil (Provigil)
Modafinil is approved for certain sleep-related conditions. It should not be presented as a standard or proven medication for methamphetamine withdrawal.
If discussed, ask the prescriber about the evidence, risks and alternatives for your particular symptoms.
4. Mirtazapine (Remeron)
Mirtazapine is an antidepressant that has been studied for reducing methamphetamine use in some populations. The findings do not establish it as an approved or universally effective withdrawal medication.
Depression, sleep, other conditions and medication risks require individual review.
5. Topiramate (Topamax)
Topiramate has approved uses for other conditions and has been studied in stimulant-use treatment. It is not an FDA-approved methamphetamine treatment.
Discuss the evidence, side effects and monitoring with the prescriber rather than selecting a medicine from a list.
Nirvana Recovery's Integrated Treatment Approach
Nirvana treats adult substance-use and co-occurring mental-health needs using CBT, DBT skills, Seeking Safety and motivational interviewing. Treatment plans are reviewed weekly with client input.
Medical and psychiatric appointments take place by telehealth, with follow-up weekly and as needed. Medication decisions are individualized. Admissions coordinates outside withdrawal care or stabilization when needed before Nirvana treatment.
Clients practice coping skills between sessions and review progress with their clinician, connecting therapy with changes in daily life.
Conclusion
Call Admissions at (480) 764-2335 to discuss methamphetamine treatment, mental-health support, program fit and preparation for care. Bring your medication list and questions for the clinical assessment.
References
Frequently Asked Questions
Prescription access does not mean a medicine is appropriate for methamphetamine treatment. A prescriber must evaluate the indication, evidence, risks and monitoring needs.
No medication is currently FDA-approved specifically for methamphetamine use disorder. The medicines discussed have other approved indications; any proposed off-label use requires individual clinical review.
Medication decisions are prescriber-led and part of an individualized plan. Nirvana provides therapy and telehealth medical and psychiatric follow-up, with outside withdrawal care or stabilization coordinated when needed.
No medication is a guaranteed cure. Ongoing care can include behavioral treatment, assessment of co-occurring symptoms and practical recovery support.
Ask what symptom or condition is being treated, the evidence for the proposed use, side effects, interactions and follow-up plan. Do not start, stop or change prescriptions based on this article.